Advanced NanoTherapies completes over $31 million Series B financing to advance dual-drug nanoparticle-coated balloon platform
Advanced NanoTherapies has secured more than $31 million in a Series B funding round led by S3 Ventures and an unnamed strategic investor. The funds will support the company's pursuit of U.S. Investigational Device Exemption (IDE), clinical development for coronary applications, and expansion into below-the-knee peripheral vascular treatments.
Topics: biotech clinical_development investments medical_devices